Announced as a focal point of future regulation in 2017, updates and guidance on both product standards for nicotine content and Tobacco Product Manufacturing Practices (TPMPs) are still pending. This session will feature a review of recent marketing granted orders, plus existing product standards and GMPs for other FDA-regulated products, to predict what they may look like for tobacco and nicotine products. Panelists will also discuss practical challenges for creating TPMPs for electronic nicotine delivery systems (ENDS) considering the variety of products that may ultimately receive marketing orders.

Panelists:
Stacey Gagosian, Managing Director, Public Policy, Truth Initiative
Neelam Gill, Associate, Keller and Heckman LLP
Beth G. Oliva, Partner, Fox Rothschild LLP
Moderated by Kristin M. Kaplan, Of Counsel, Shook, Hardy & Bacon LLP